Clinical Research Directory
Browse clinical research sites, groups, and studies.
Colorectal Pulmonary Metastases: Pulmonary Metastasectomy Versus Stereotactic Ablative Radiotherapy
Sponsor: Amsterdam UMC, location VUmc
Summary
COPPER is an international, multicenter, parallel-arm, phase III randomized controlled trial comparing two local treatment strategies (SABR or metastasectomy) for patients with an indication for local treatment for limited (max. three) colorectal pulmonary metastases
Official title: Colorectal Pulmonary Metastases: Pulmonary Metastasectomy Versus Stereotactic Ablative Radiotherapy: a Phase III Multicenter Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
394
Start Date
2024-01-01
Completion Date
2030-12-31
Last Updated
2023-04-11
Healthy Volunteers
No
Interventions
Minimally invasive pulmonary metastasectomy
Surgical margin is equal to tumor size, if possible The goal is a parenchymal-sparing resection
Stereotactic ablative radiotherapy
Depending on tumor location, 54 Gy in 3 fractions, 55 Gy in 5 fractions, 60 Gy in 8 fractions.
Locations (1)
Amsterdam University Medical Center (AUMC)
Amsterdam, Netherlands